Prof. Amira Badr | Biochemistry | Best Researcher Award
Professor of Pharmacology and Toxicology, King Saud University, Saudi Arabia.
Dr. Amira Mohammad Abd Elrahim Mohammad Badr is an Associate Professor of Pharmacology and Toxicology at Ain Shams University, Egypt, and King Saud University, Saudi Arabia. She has over two decades of academic and research experience, having made significant contributions to pharmacological and toxicological sciences. Her expertise spans neuropharmacology, cardiovascular pharmacology, environmental toxicology, and chemotherapy-induced organ toxicity. Dr. Badr has published extensively in high-impact journals and participated in numerous national and international conferences. She has supervised several Master’s and PhD theses and served on thesis examination committees. Her academic excellence has earned her recognition among the world’s top 2% scientists by Stanford University. She is also actively involved in curriculum development, quality assurance, and faculty training programs. In addition to her academic achievements, Dr. Badr has contributed to peer review processes and editorial roles in prestigious journals. Her research continues to impact both scientific knowledge and public health policy.
Professional Profile
Dr. Amira Badr holds a distinguished academic record in pharmaceutical sciences from Ain Shams University, Cairo, Egypt. She earned her Ph.D. in Pharmaceutical Sciences with a thesis focusing on the pharmacological outcomes of carvedilol and carnitine in treating myocardial infarction in rats. This was preceded by a Master’s degree, where she investigated the hepatoprotective effects of natural products. Her undergraduate education culminated in a Bachelor of Science in Pharmaceutical Sciences , where she graduated with top honors, ranking first among her peers. Throughout her academic journey, Dr. Badr has demonstrated consistent academic excellence, producing impactful research that led to journal publications at each level of study. Her educational background laid a solid foundation for her specialization in pharmacology and toxicology and provided her with critical analytical and experimental skills. These have fueled her passion for academic teaching, mentoring, and cutting-edge biomedical research over the years.
Experience
Dr. Amira Badr possesses over 20 years of academic experience in pharmacology and toxicology. Her career began as an instructor at Ain Shams University, followed by roles as an assistant lecturer and lecturer. she transitioned to King Saud University, where she progressed from Assistant to Associate Professor. Parallel to her roles in Saudi Arabia, she maintained affiliations with Ain Shams University, reflecting her dual academic presence. Dr. Badr has taught numerous undergraduate and postgraduate courses in pharmacology, toxicology, and biochemistry. Her extensive teaching includes advanced topics such as neuropharmacology, pharmacogenomics, and industrial toxicology. She also served as a mentor for numerous graduation projects and supervised multiple Master’s theses. In addition to teaching, she has been involved in quality assurance, scientific committees, and student evaluation processes. Her multifaceted experience spans research leadership, academic governance, and scientific mentorship, demonstrating her deep commitment to both education and biomedical research.
Professional Development
Dr. Amira Badr has pursued comprehensive professional development, undertaking over 25 training courses spanning teaching methodologies, research ethics, scientific writing, technology in education, and leadership. At Ain Shams University, she completed programs on communication skills, teaching effectiveness, research methods, and exam evaluation. Later, she expanded her expertise through advanced courses in e-learning, stress management, sustainable development, and conference organization. At King Saud University, she undertook specialized training in microteaching, capstone course design, and digital tools such as Blackboard, EndNote, and Photoshop. She also completed training in project management and program learning outcome assessments, aligning her work with modern academic standards and national qualification frameworks. Her role as a trainer for new academic staff further illustrates her leadership in academic capacity building. These continued development efforts reflect her dedication to remaining at the forefront of academic excellence and innovation, enhancing both her teaching capabilities and research supervision effectiveness in a dynamic educational environment.
Skills & Expertise
Dr. Amira Badr brings a diverse skill set that spans research, teaching, leadership, and scientific communication. Her core competencies include experimental pharmacology, toxicological assessments, molecular biology techniques, and preclinical models of organ toxicity. She is adept at teaching undergraduate and postgraduate courses, having developed and delivered curricula in basic and advanced pharmacology, clinical toxicology, and pharmacogenomics. She is proficient in scientific writing, manuscript editing, and supervising graduate research, with many students successfully completing their theses under her guidance. Her technical capabilities include using academic platforms like Blackboard, EndNote, and CourseLab. Dr. Badr also demonstrates strong administrative and organizational skills, evident from her roles in academic committees, quality assurance, and faculty training. Her participation in workshops on leadership, time management, digital tools, and e-learning reflects a continuous drive for self-improvement. Her combination of scientific acumen, teaching excellence, and project leadership make her a well-rounded and highly effective academic professional.
Resarch Focus
Dr. Amira Badr’s research is centered on pharmacology and toxicology, with a specialized focus on organ protection from chemotherapy-induced damage, neuropharmacology, cardiovascular pharmacology, and metabolic disorders such as non-alcoholic fatty liver disease. She investigates protective mechanisms of natural compounds and pharmacological agents against oxidative stress, inflammation, and apoptosis in preclinical models. Her research integrates molecular pharmacology, pathophysiology, and experimental toxicology, particularly emphasizing the modulation of signaling pathways like TLR4/NF-κB, Notch, and SIRT1/Nrf2 in disease progression and drug response. She is also engaged in environmental toxicology, exploring the effects of pollutants such as microplastics and heavy metals on organ systems. Her translational approach aims to bridge bench-side discoveries with therapeutic potential. Notably, her recent work has explored drug delivery systems, phytotherapy, and molecular targets in cancer and kidney diseases. Dr. Badr’s holistic and multidisciplinary research positions her at the forefront of pharmacological innovation aimed at safer, more effective therapeutic strategies.
Awards & Recognitions
Dr. Amira Badr has earned notable recognition throughout her academic career. Most prominently, she has been included in Stanford University’s global list of the top 2% of scientists based on Scopus-indexed data, reflecting her influential contributions to pharmacology and toxicology. With over 1088 citations and an h-index of 16 (Google Scholar), she has demonstrated consistent scholarly impact. She has served as the principal investigator of a research group funded by the Deanship of Scientific Research at King Saud University. Additionally, she holds the position of Academic Editor at Oxidative Medicine and Cellular Longevity and has reviewed over 40 manuscripts for top-tier ISI journals. Her extensive involvement in academic committees, research days, and scientific poster and oral presentations further underscores her leadership and commitment to scientific advancement. These honors validate her reputation as an accomplished researcher and educator in her field, both nationally and internationally.
Publication Top Notes
-
Publication: Rubus sanctus protects against carbon tetrachloride-induced toxicity in isolated rat hepatocytes
Authors: Unknown
Year: 2019
Citation: Journal of Pharmacy and Pharmacology. 2019 Nov;861(11):1511-20. -
Publication: Sodium selenite treatment restores long-lasting ovarian damage induced by irradiation in rats
Authors: Unknown
Year: 2014
Citation: Reprod Toxicol. 2014 Jan; 43:85-93. -
Publication: Chrysin alleviates acute doxorubicin cardiotoxicity in rats
Authors: Unknown
Year: 2014
Citation: Eur J Pharmacol. 2014 Apr 5;728:107-18. -
Publication: Anti-apoptotic and Anti-inflammatory Effects of Olive Leaf Extract Against Cisplatin-induced Nephrotoxicity
Authors: Unknown
Year: 2016
Citation: Int J Pharmacol. 2016; 675-689. -
Publication: Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats
Authors: Unknown
Year: 2019
Citation: Biochem Pharmacol. 2019 Jun;164:252-262. -
Publication: Implication of Sphingosine-1-P/Sphingosine Kinase Pathway in Non-alcoholic Fatty Liver Disease
Authors: Unknown
Year: 2019
Citation: Adv Res Gastroentero Hepatol, May 2019, Vol 13(1), DOI: 10.19080/ARGH.2019.13.555855. -
Publication: Hepatoprotective activity of raspberry ketone in acute liver injury
Authors: Unknown
Year: 2019
Citation: Toxicol. Res., 2019. https://doi.org/10.1039/C9TX00068B. -
Publication: Crosstalk of Nrf2 with NOXs, and HMGB1 in Ethanol-Induced Gastric Ulcer
Authors: Unknown
Year: 2019
Citation: PLOS ONE, 2019. Accepted Article. -
Publication: Carvacrol and Thymol in radiotherapy-induced ovarian failure
Authors: Unknown
Year: 2019
Citation: Oxidative Medicine and Cellular Longevity, 2019. -
Publication: Protective Mechanisms of Dandelion Leaf Extract Against Cisplatin-Induced Nephrotoxicity
Authors: Unknown
Year: 2019
Citation: Dose-Response, 2019. -
Publication: Arctium Lappa Root Extract Prevents Lead-Induced Liver Injury
Authors: Unknown
Year: 2019
Citation: Antioxidants. 2019 Nov 24;8(12).
Conclusion:
Dr. Amira Badr’s extensive research contributions, recognized scientific impact, and leadership in toxicology and pharmacology make her an outstanding contender for the Best Researcher Award. Her profile aligns strongly with the award’s core criteria: research excellence, originality, societal impact, and mentorship. With continued international collaboration and translational focus, she is poised to make even greater global contributions to biomedical science.